| |
|
|
| |
|
|
| |
|
|
|
| |
recent
postings |
|
| |
August 13, 2026 |
central portal site to HUMan MOLecular
GENetics
|
|
| |
|
|
|
|
|
|
|
New content on this website from the last 14 days.
Meetings
- Meetings and Conferences:
Microbiology / Virology: The rapid growth of GLP-1 receptor agonists, dual agonists and other emerging therapies is accelerating drug development across obesity and type 2 diabetes. At the same time, sponsors face increasing
Optimize Obesity Development: Endpoint Strategies for Early-phase Innovation to Late-phase Differentiation
Xtalks — The Life Science Community™, Online webinar
2026-09-17
- Meetings and Conferences:
Others: As bispecifics and other complex biologics move through clinical development and into commercial programmes, downstream teams are under increasing pressure to deliver purification processes that are s
Expand Bispecific Purification Strategies Beyond mAb Platforms
Xtalks — The Life Science Community™, Online webinar
2026-09-17
- Meetings and Conferences:
Others: Pharmacovigilance teams are managing more complex development programs, expanding data sources, and growing volumes of safety information. They must also maintain compliant, inspection-ready systems a
AI-Enabled Pharmacovigilance: Practical Strategies for Smarter Safety Operations
Xtalks — The Life Science Community™, Online webinar
2026-09-10
- Meetings and Conferences:
Microbiology / Virology: Regulators increasingly want to see the patient voice included to inform drug development, and in-trial patient interviews are one of the most direct ways to capture it. Done well, they transform pati
A Comprehensive Guide to Conducting In-Trial Patient Interviews
Xtalks — The Life Science Community™, Online webinar
2026-09-16
Companies
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2026 HUM-MOLGEN.
All rights reserved.
Liability, Copyright and Imprint.
|
|